Biocryst Pharmaceuticals (BCRX) Total Debt Growth (1y) (2012 - 2026)
Biocryst Pharmaceuticals (BCRX) Total Debt Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -0.14% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 37.52% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -92.65% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -9.19% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 0.63% |
| 10 | Biocryst Pharmaceuticals | 2.02 Bn | 1.78 Bn | 151.04 Mn | 24.53% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.53% |
| Dec 31, 2025 | -88.94% |
| Sep 30, 2025 | -33.19% |
| Jun 30, 2025 | -18.75% |
| Mar 31, 2025 | 4.55% |
| Dec 31, 2024 | 6.35% |
| Sep 30, 2024 | 16.56% |
| Jun 30, 2024 | 16.92% |
| Mar 31, 2024 | 43.86% |
| Dec 31, 2023 | 41.09% |
| Sep 30, 2023 | 33.11% |
| Jun 30, 2023 | 102.87% |
| Mar 31, 2023 | 65.81% |
| Dec 31, 2022 | 70.21% |
| Sep 30, 2022 | 69.53% |
| Jun 30, 2022 | 13.98% |
| Mar 31, 2022 | 13.98% |
| Dec 31, 2021 | 13.65% |
| Sep 30, 2021 | 186.81% |
| Mar 31, 2021 | 143.45% |